KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Debt Ratio (2009 - 2016)

Vertex Pharmaceuticals' quarterly Debt Ratio came in at 0.1 in Q4 2016, down 12.33% year-on-year from 0.12 in Q1 2016, and down 9.23% quarter-over-quarter from 0.11 in Q3 2016.

Vertex Pharmaceuticals has reported Debt Ratio for 6 years, with the latest figure at 0.1 in Q4 2016.

  • For the quarter ending Q4 2016, Debt Ratio fell 12.33% year-over-year to 0.1; the trailing twelve-month figure through Dec 2016 stood at 0.1 (down 12.33% YoY), and the FY2016 full-year result was 0.1, down 12.33% from the prior year.
  • Debt Ratio for Q4 2016 stood at 0.1, down from 0.11 in the prior quarter.
  • The five-year high for Debt Ratio was 0.14 in Q1 2015, with the low at 0.1 in Q4 2016.
  • Average Debt Ratio over 3 years is 0.12, with a median of 0.12 recorded in 2015.
  • Year-over-year, Debt Ratio retreated 1.12% in 2015 and decreased 12.64% in 2016.
  • Tracing VRTX's Debt Ratio over 3 years: stood at 0.13 in 2014, then decreased by 6.44% to 0.12 in 2015, then retreated by 12.33% to 0.1 in 2016.
  • The last three Debt Ratio figures came in at 0.1 (Q4 2016), 0.11 (Q3 2016), and 0.12 (Q2 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 0.10
Sep 30, 2016 0.11
Jun 30, 2016 0.12
Mar 31, 2016 0.12
Dec 31, 2015 0.12
Sep 30, 2015 0.12
Jun 30, 2015 0.12
Mar 31, 2015 0.14
Dec 31, 2014 0.13
Sep 30, 2014 0.12
Sep 30, 2011 0.05
Mar 31, 2011 0.06
Dec 31, 2010 0.05
Sep 30, 2010 0.02
Jun 30, 2010 0.10
Dec 31, 2009 0.07